Reversal of J&J $72m verdict over talc cancer risks
Johnson & Johnson has won the reversal of a $72m (€61.3m) verdict in the US in favour of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.
Business
• 18 Oct 17